Aurora Cannabis (ACB) Cash from Operations (2017 - 2026)

Aurora Cannabis (ACB) posted quarterly Cash from Operations of 2413000.0 for Q1 2026, down 64.34% year-on-year from 6767000.0 in Q1 2025, and down 87.99% on a QoQ basis from 20090000.0 in Q4 2025.

Aurora Cannabis (ACB) Cash from Operations (2017 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash from Operations for 10 consecutive years, with 2413000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Operations fell 64.34% year-over-year to 2413000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49914373.36 (up 184.58% YoY) and the FY2026 annual result came in at 5664416.07, down 129.86% from the prior year.
  • Cash from Operations retreated to 2413000.0 in Q1 2026 per ACB's latest filing, from 20090000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for ACB reached as high as 20644373.36 in Q4 2024 and fell as low as 87260253.14 in Q4 2022.
  • A 5-year average of 14290302.42 and a median of 15677141.52 in 2024 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2022 — Cash from Operations plunged 740.21% — and 2024, when it soared 633.92%.
  • Year by year, Cash from Operations stood at 87260253.14 in 2022, then surged by 95.57% to 3866595.01 in 2023, then surged by 633.92% to 20644373.36 in 2024, then decreased by 2.69% to 20090000.0 in 2025, then slumped by 87.99% to 2413000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 2413000.0, 20090000.0, and 6767000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 2.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.41 Mn
Mar 31, 2026 2.41 Mn
Dec 31, 2025 20.09 Mn
Dec 31, 2025 20.09 Mn
Mar 31, 2025 6.77 Mn
Mar 31, 2025 6.77 Mn
Dec 31, 2024 20.64 Mn
Dec 31, 2024 20.64 Mn
Sep 30, 2024 -18.25 Mn
Sep 30, 2024 -18.25 Mn
Jun 30, 2024 8.38 Mn
Jun 30, 2024 8.38 Mn
Mar 31, 2024 -15.68 Mn
Mar 31, 2024 -15.68 Mn
Dec 31, 2023 -3.87 Mn
Dec 31, 2023 -3.87 Mn
Sep 30, 2023 -23.04 Mn
Sep 30, 2023 -23.04 Mn
Dec 31, 2022 -87.26 Mn
Dec 31, 2022 -87.26 Mn